This target was identified as a potential target of 17 metabolites of sibirioside A and angoroside C. Defects in INSR cause insulin resistance, leprechaunism, noninsulin-dependent diabetes mellitus, and familial hyperinsulinemic hypoglycemia. This evidence concerns the gene INSR and type 2 diabetes mellitus.